CollPlant Biotechnologies (CLGN) Prepaid Assets (2018 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Prepaid Assets came in at $223000.0 in Q4 2025, down 99.95% YoY from $433.0 million in Q4 2024, and down 38.74% on a QoQ basis from $364000.0 in Q2 2025.
CollPlant Biotechnologies (CLGN) Prepaid Assets (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 8 years of Prepaid Assets data on file, last reported at $223000.0 in Q4 2025.
- Quarterly Prepaid Assets fell 99.95% year-over-year to $223000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $223000.0 (down 99.95% YoY) and the FY2025 annual result came in at $223000.0, down 99.95% from the prior year.
- Prepaid Assets retreated to $223000.0 in Q4 2025, from $364000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $424.0 billion in Q4 2021 to a low of $223000.0 in Q4 2025.
- A 5-year average of $23.7 billion and a median of $750500.0 in 2021 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2021 — Prepaid Assets jumped 177405757.74% — and 2025, when it sank 99.95%.
- Tracing CLGN's Prepaid Assets over 5 years: stood at $424.0 billion in 2021, then plunged by 99.87% to $543.0 million in 2022, then plunged by 99.93% to $393000.0 in 2023, then soared by 110078.12% to $433.0 million in 2024, then slumped by 99.95% to $223000.0 in 2025.
- The last three Prepaid Assets figures came in at $223000.0 (Q4 2025), $364000.0 (Q2 2025), and $433.0 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 223,000.00 |
| Jun 30, 2025 | 364,000.00 |
| Dec 31, 2024 | 433.00 Mn |
| Sep 30, 2024 | 426.00 Mn |
| Jun 30, 2024 | 490,000.00 |
| Mar 31, 2024 | 279.00 Mn |
| Dec 31, 2023 | 393,000.00 |
| Sep 30, 2023 | 493.00 Mn |
| Jun 30, 2023 | 758,000.00 |
| Mar 31, 2023 | 408,000.00 |
| Dec 31, 2022 | 543.00 Mn |
| Sep 30, 2022 | 489,000.00 |
| Jun 30, 2022 | 594,000.00 |
| Mar 31, 2022 | 263,000.00 |
| Dec 31, 2021 | 424.00 Bn |
| Sep 30, 2021 | 743,000.00 |
| Jun 30, 2021 | 979,000.00 |
| Mar 31, 2021 | 267.00 Mn |
| Dec 31, 2020 | 239,000.00 |
| Sep 30, 2020 | 550,000.00 |